Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

388 results for Pharmaceuticals
Filters
Refine your search
CLEAR ALL
A. Costantino & C. S.P.A
Protease designed for pharmaceutical preparations. It is suitable for in-vitro cell testing and parasite detection. Shelf life: 30 months. Benefits:
  • Nanoparticles and GMO-free
  • Shows activity in acid environments between 37°C and 42°C
  • Proteolytic Activity 1:10000 NF/USP = 2000-2200 U/g FIP
  • TSE/BSE…
A. Costantino & C. S.P.A
Peptone designed for pharmaceutical applications. It is a desiccated liver powder from Italian pork liver. Shelf life: 3 years. Benefits:
  • Mask unpleasant taste
  • Improves palatability of the final product
  • Nanoparticles and GMO-free
  • TSE/BSE contamination free
A. Costantino & C. S.P.A
Peptone designed for pharmaceutical preparations. It is a liver powder from chicken liver. Shelf life: 3 years. Benefits:
  • Mask unpleasant taste
  • Improves palatability of the final product
  • Nanoparticles and GMO-free
  • TSE/BSE contamination free
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Bulking agent and antioxidant specially developed for solid and semi-solid dosage forms.Benefits:
  • pH adjustment
  • Clear and colorless or not more intensely colored than reference solution Y7, BY7 or GY7
Actylis
Preservative specially developed for injectable formulations, solid and semi-solid dosage forms.Benefits:
  • DMF Filed
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc) 
Actylis
Excipient for use in pharmaceutical applications.Benefits:
  • Acts as a preservative
Actylis
Excipient for pharmaceutical applications.Benefits:
  • Effloresces in warm, dry air. Its solutions are alkaline to phenolphthalein TS, a 0.1 M solution having a pH of about 9
  • Freely soluble in water, very slightly soluble in alcohol
Actylis
Excipient recommended for pharmaceutical applications.
Actylis
Coating agent developed for solid and semi-solid dosage forms.Benefits:
  • Strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Solvent designed for oral solid dosage formulations. It acts as a permeation enhancer for transdermal patches. It is used as a humectant for solid and semi-solid dosage forms. Benefits:
  • Highly pure
  • Improves drug efficacy